AUAUniversity Podcast Series: Episode No. 33

Adjuvant Therapy in Renal Cell Carcinoma

Co-Host: Alexander Kutikov, MD, FACS

At the conclusion of these activities, participants will be able to:
1. Discuss the evolving landscape of adjuvant therapy for the treatment of RCC.
2. Identify best practices for risk assessment and patient selection for adjuvant RCC therapy.
3. Differentiate the roles of urologist and medical oncologist in the care of patients with RCC.

This educational series is supported by independent educational grants from:
Bristol-Myers Squibb
Genomic Health
Pfizer, Inc.
Sanofi Genzyme
UroGen Pharma